Mulpleta (lusutrombopag) — United Healthcare
thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo a procedure
Preferred products
- Doptelet (avatrombopag)
Initial criteria
- Diagnosis of thrombocytopenia
- AND Patient has chronic liver disease
- AND Patient is scheduled to undergo a procedure
- AND History of failure, contraindication, or intolerance to Doptelet (avatrombopag)
Approval duration
1 month